摘要
目的:探讨PTCH1基因甲基化在胃癌发生中的作用及去甲基化试剂5-氮杂-2′-脱氧胞苷(5-Aza-dC)对胃癌的治疗作用。方法:选取10例胃癌组织及其癌旁正常组织和胃癌细胞株AGS,抽提组织和细胞的总RNA和基因组DNA。实时定量QRT-PCR检测PTCH1基因的mRNA表达,MSP(methylation specific PCR)分析PTCH1基因启动子区甲基化变化。用5-Aza-dC处理AGS细胞株,流式细胞术检测细胞周期和凋亡并观察PTCH1基因甲基化水平的改变。结果:胃癌组织、癌旁正常组织和胃癌细胞株AGS中PTCH1基因表达和启动子甲基化水平呈负相关,相关系数为-0.591(P=0.006);5-Aza-dC的处理可引起胃癌细胞AGS细胞发生凋亡和G0/G1期阻滞,PTCH1基因发生去甲基化变化并表达增加。结论:PTCH1基因启动子区高甲基化是胃癌细胞PTCH1低表达主要原因之一,5-Aza-dC能逆转PTCH1基因甲基化状态,调控其表达,对胃癌具有一定的治疗作用。
Objective:To study the effect of PTCH1 methylation on gastric carcinogenesis and the therapeutic effect of methylation inhibitor,5-aza-2′-deoxyeytidine (5-aza-dC), for treatment of gastric cancer.Methods: The total RNAs were extracted from 10 gastric cancer tissues,their corresponding adjacent normal tissues, and gastric cancer cell line AGS.The PTCH1 mRNA expression was detected by Quantitative real-time PCR (QRT-PCR) and the methylation of the promoter was examined by methylation specific PCR (MSP).AGS cells were treated by 5-Aza-dC; the cell cycle and apoptosis were examined by flow cytometry,and the methylation level was also observed.Results: PTCH1 expression was negatively correlated with promoter methylation in gastric cancer tissues,their corresponding adjacent normal tissues, and gastric cancer cell line AGS(r=-0.591,P=0.006).5-Aza-dC treatment caused apoptosis and G0/G1 phase arrest of AGS cells,and also induced demethylation of PTCH1 and increased its expression.Conclusion: Hypermethylation of PTCH1 gene promoter region is one of the main causes of low PTCH1 expression in AGS cells.Demethylation agent 5-Aza-dC can reverse this methylation status of PTCH1 and regulate the expression of PTCH1,suggesting a role for it in gastric cancer treatment.
出处
《第二军医大学学报》
CAS
CSCD
北大核心
2009年第8期884-887,共4页
Academic Journal of Second Military Medical University